Gender-based issues in interventional cardiology: a consensus statement from the Women in Innovations (WIN) initiative
EuroIntervention 2010;5:773-779.
Alaide Chieffo1*, MD; Angela Hoye2, MB, ChB, PhD; Fina Mauri3, MD, PhD; Ghada W. Mikhail4, MD, FRCP; Michelle Ammerer5, MD; Cindy Grines6, MD; Liliana Grinfeld7, MD; Mina Madan8, MD, MHS; Patrizia Presbitero9, MD; Kimberly A. Skelding10, MD, FACC, FAHA, FSCAI; Bonnie H. Weiner11, MD; Roxana Mehran12, MD; on behalf of the WIN Group
1. San Raffaele Scientific Institute, Invasive Cardiology Unit, Milan, Italy; 2. Castle Hill Hospital, Invasive Cardiology Unit, Hull, East Yorkshire, United Kingdom; 3. Hospital Germans Trias I Pujol, Invasive Cardiology Unit, HCA, Badalona, Spain; 4. De
Cardiovascular disease (CVD) is the leading cause of mortality in women, yet studies have suggested that it is often under-recognized. Of particular concern is the apparent suboptimal treatment of women in compar